Demonstration of Point-of-care Testing Value Continues to Drive Adoption

 

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

Studies have shown that rapid turnaround times allowed by point-of-care testing (POCT) can improve patient outcomes by avoiding inefficiencies in administrative follow-ups, and minimizing delays in treatments that could otherwise result in adverse complications and costly consequences. These types of studies continue to support the value of POCT and drive adoption. The value of immediate diagnostics results is most evident in testing for infectious diseases and cardiac events.

Table of Contents

Demonstration of Point-of-care Testing Value Continues to Drive AdoptionDemonstration of Point-of-care Testing Value Continues to Drive AdoptionDemonstration of Point-of-care Testing Value Continues to Drive Adoption




Related Research

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 15-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.